The exosome therapeutics field is booming with anticipation as preparations are underway for the first few clinical trials and money pours in through partnerships and pipeline acquisitions. However, more is needed to be done to uncover more scientific knowledge, fine-tune manufacturing methods and prepare trials to meet regulatory expectations.
Considering this, the 2nd Digital Exosome Based Therapeutic Development Summit (November 11-12, 2020) will unite pharma, biotech, academic and technology providers to advance exosome therapeutics into a clinical and commercial reality.
This is your only industry-focused meeting dedicated specifically to evidence-based and regulated exosome-based therapeutics. Bringing together industry leaders and newcomers on the field, it’s two days not to be missed.
With 20+ speakers and 2 days of unrivalled in-depth content, join your peers to discuss:
- End-to-end insights on drug development from discovery to scalable manufacturing of GMP-grade exosomes, clinical preparation, commercial strategy and more with Evox Therapeutics, Aruna Bio, Codiak Biosciences and ReNeuron
- Innovations in exosome-based therapeutics, such as their applications in COVID-19 vaccines with Capricor Therapeutics
- Understanding the underlying mechanisms of exosome interactions to inform target identification and development decisions with Scripps Research and University Hospital Essen
- Preparing for clinical trials with key lessons learned from the best in the business such as Aegle Therapeutics
- Over 4+ hours scheduled virtual networking time to connect with the community all from the comfort of your own home or office!
If you are exploring the therapeutic applications of exosomes in an evidence-based approach, this is the place for you.
Spanning 2 days, this digital program is tailor-made to showcase the field’s most exciting breakthroughs to inform your discovery, manufacturing, commercial and regulatory strategies. Join this interactive forum this November to drive GMP-grade manufacturing methods, consistent exosome production, improved isolation and purification, effective clinical and regulatory preparations, beneficial industry partnerships and more.
To know more about 2nd Digital Exosome Based Therapeutic Development Summit please click here.